Benefits of Targeting Both Pericytes and Endothelial Cells in the Tumor Vasculature With Kinase Inhibitors
Journal of Clinical Investigation - United States
doi 10.1172/jci200317929
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2003
Authors
Publisher
American Society for Clinical Investigation